Located in Durham, North Carolina, Accord Healthcare is an emerging large-scale provider of generic pharmaceuticals in the United States.
Located in Durham, North Carolina, Accord Healthcare is an emerging large-scale provider of generic pharmaceuticals in the United States. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976.
The Accord and Intas organizations are a true global distribution network, with presence in over 70 countries worldwide. Over the past decade, we have built the formulation expertise and manufacturing capacity to directly supply a vast portfolio of generic oral solids and injectables, oncology injectables, specialty injectables, and biologics to the regulated markets.
SOLID, SUSTAINABLE GROWTH
Since 2009, we have been delivering reliable supply and quality excellence in products sold in the U.S. under the Accord label. Our goals toward growth continue to be aggressive and have always been matched by our commitment to exceed our customers’ expectations. We are currently the market share leader in more than half of the product markets we supply.
Accord is routinely cited in IMS presentations to industry as one of the fastest growing pharmaceutical companies in the U.S. Quarter-over-quarter, we consistently accomplish double-digit growth across all the metrics: in dollar sales, scripts filled, and number of units sold. We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing such tremendous commercial expansion has set us apart in the industry.
Accord’s product offerings and pipeline demonstrate our commitment to meeting the needs of healthcare professionals and patients alike. We currently have approval for 77 ANDAs and are selling 250 dosing presentations. We have 68 ANDAs pending at the FDA, and over 110 products in active development. Our pipeline spans a full range of dosage forms: orals, topicals, transdermal patches, liquid, lyophilized and peptide injectables.
Accord is integrated in key areas such as active pharmaceutical ingredients and pharmaceutical component manufacturing, as well as clinical research management. Our R&D operation is staffed with a 450+ member distinguished scientific team. Our state-of-the-art labs and manufacturing infrastructure provide the right environment for true innovation.
At Accord, we are committed to Improving Lives through Innovation.